Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.60 |
| ▸ | PPARD | Q03181 | 8/20 | 0.60 |
| ▸ | PPARA | Q07869 | 8/20 | 0.60 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.38 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6938923 | 0.91 | PPARG (0.57) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6938970 | 0.89 | PPARG (0.75) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6936047 | 0.88 | PPARG (0.62) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6936610 | 0.87 | PPARG (0.80) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6936607 | 0.87 | PPARG (0.80) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6938100 | 0.84 | PPARG (0.69) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6937554 | 0.84 | PPARG (0.68) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6937558 | 0.84 | PPARG (0.68) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6939647 | 0.81 | PPARG (0.62) | PPARGPPARDPPARACYSLTR1CYSLTR2 | |
| SCHEMBL6936040 | 0.80 | PPARG (0.63) | PPARGPPARDPPARACYSLTR1CYSLTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888278-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | claimed |